Clinerion, a leader in real-world data solutions, is helping bring medical data informatics to the life sciences industry. CEO Barış Erdoğan explains how the company is creating and applying technology to significantly reduce the drug development timeline. Clinerion uses Big Data analytics technologies to help hospitals, pharmaceutical companies and research organizations identify high-risk patients for different diseases, improve the market access process, respecting privacy laws and regulations along the way.
There is a huge interest now for healthcare data analysis to better protect people from the effects of the [corona]virus. This is really opening new doors, allowing us to increase our client base, as well as increase our use cases
